Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
Competitive APIs

Retapamulin 224452-66-8

Retapamulin 224452-66-8
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.

Retapamulin is used to treat impetigo (a skin infection caused by bacteria) in children and adults. Retapamulin is in a class of medications called antibacterials. It works by killing and stopping the growth of bacteria on the skin.

GMP for Retapamulin is not available yet, DMF for Retapamulin is under preparation
 
Disclaimer:Those products (Retapamulin 224452-66-8) are for lab analytical & research purposes only.